Among the nine subtypes of human voltage-gated Na + (Na v ) channels, tetrodotoxin (TTX)-resistant Na v 1.5 is the primary one in heart. More than 400 point mutations have been identified in Na v 1.5 that are associated with cardiac disorders exemplified by type 3 long QT syndrome and Brugada syndrome, making Na v 1.5 a common target for class I antiarrythmic drugs. Here we present the cryo-EM structures of Na v 1.5 bound to quinidine and TTX with resolutions at 3.2 Å and 3.3 Å, respectively, for the pore domain. The structures allow mapping of 278 disease-related mutations in the resolved region, establishing the framework for mechanistic investigation of these pathogenic mutations. Quinidine is positioned right below the selectivity filter and coordinated by residues from repeats I, III, and IV. Pore blockade is achieved through both direct obstruction of the ion permeation path and induced rotation of a Tyr residue that leads to intracellular gate closure. Structural comparison of Na v 1.5 with our previously reported Na v 1.2/1.4/1.7 reveals the molecular determinant for the different susceptibility to TTX by TTX-resistant and -sensitive Na v subtypes, and highlights the functional significance of the underexplored and least conserved extracellular loops.
Introduction
Each heartbeat is a result of sophisticated cooperation of multiple signaling events, including transmission of electrical impulses, conversion of the membrane electrical signals to the intracellular chemical signals, and eventually the contraction of cardiomyocytes (1, 2) . Among these, the initiation of an action potential is mainly mediated by the cardiac subtype of voltage-gated sodium (Nav) channels, Nav1.5, which is insensitive to tetrodotoxin (TTX) and encoded by the gene SCN5A (3) . Due to its essential physiological function, it is not surprising that among the over 1000 identified disease mutations known in the nine human Nav channels, more than 400 have been found in Nav1.5 (Tables S1-S3) (4) .
Gain or loss of function (GOF or LOF) of Nav1.5 can both be pathogenic (5) (6) (7) (8) (9) (10) (11) . LOF mutations, which may result in reduced Na + peak current INa or prolonged inactivation, are associated with Brugada syndrome, sick sinus syndrome, and cardiac conduction defect. GOF mutations can lead to type 3 Long QT (LQT3) syndrome, sudden infant death syndrome, and stillbirth. A common arrhythmia, atrial fibrillation, can be associated with either GOF or LOF. Nav1.5, on one hand, is a primary target for class I antiarrythmic drugs, which are Nav blockers and further classified to Ia, Ib and Ic (12) . On the other hand, Nav1.5, similar to the cardiac potassium channel hERG, has to be avoided for general drug development due to potential off-target activity (13, 14) . Therefore, a detailed structure of human Nav1.5 is required to understand its pathophysiology and to facilitate drug discovery.
In the past three years, we have reported the cryo-EM structures, at resolutions ranging between 2.6-4.0 Å, of Nav channels from insect (NavPaS), electric eel (EeNav1.4), and finally human, including Nav1.2, Nav1.4, and Nav1.7 that function respectively in the central nervous system, skeletal muscle, and sensory neurons (15) (16) (17) (18) (19) (20) . Apart from the first structure of a eukaryotic Nav channel, NavPaS, whose pore domain has no fenestration and VSDs are only partially "up", all other Nav channels exhibit similar conformations with voltage-sensing domains (VSDs) in the depolarized "up" states and the fast inactivation motif plugging into a structurally-revealed receptor cavity between the S6 pore helices and the S4-S5 restriction helices in repeats III and IV. Because of the high sequence similarity, the structures of these Nav channels in complex with distinct auxiliary subunits and small molecule or peptidic toxins, elucidate the folding principle of the single chain voltage-gated ion channels, the details of the Na + permeation path through the Asp/Glu/Lys/Ala (DEKA)-constituted selectivity filter (SF), the mechanism of fast inactivation, and the molecular basis for specific recognition and mechanism of action of various modulators. These structures also provide the molecular template to study hundreds of disease mutations.
On the basis of the previous progress, our incentive for structural investigation of Nav1.5 is to unveil its interplay with representative ligands and to identify distinct features that may facilitate development of specific therapeutics targeting different Nav subtypes. Here we present the structures of full-length human Nav1.5 in the presence of TTX or quinidine, a class Ia antiarrythmic drug, determined using single-particle cryo-EM. To avoid redundancy with previous structural illustrations, we focus our analysis on the unique features of Nav1.5.
Results

Cryo-EM analysis of human Na v 1.5
Full-length human Nav1.5 was transiently co-expressed with the β1 subunit in HEK293F cells using plasmids and purified through tandem affinity column and size exclusion chromatography ( Figure 1A ). We chose β1 to be co-expressed with Nav1.5, because TTX-resistant Na + current was elevated when Nav1.5 was coexpressed with β1, although there was little effect on the activation and inactivation curves ( Figure 1B , Figure S1 , Table S4 ). This observation is consistent with the previous report of increased expression level of Nav1.5 in the presence of the β1 subunit (21) .
The freshly purified protein, at concentration of approximately 1 mg/ml, was either incubated with 66 μM tetrodotoxin (TTX) and ~200 μM untagged calmodulin (CaM), or 1 mM quinidine and 12 μM saxitoxin (STX) for 30 min. The samples, named Nav1.5-TC in the presence of TTX and CaM, and Nav1.5-QS with quinidine and STX, were applied for cryo-grid preparation, image acquisition, and data processing. EM maps were obtained at overall resolutions of 3.4 Å and 3.3 Å out of 145,139 and 124,954 selected particles, respectively. The resolutions for the central region were respectively improved to 3.3 Å and 3.2 Å after application of a soft mask ( Figure 1C , Figures S2-S4 , Table S5 ). The 3D reconstruction maps for Nav1.5-TC and Nav1.5-QS are similar ( Figure S2C ). We will focus on one map for overall structural description.
Compared to the 3D reconstructions for human Nav1.2 in complex with β2, Nav1.4 with β1, and Nav1.7 with both β1 and β2, that of Nav1.5 apparently lacks the density for any auxiliary subunit although β1 was co-expressed ( Figure S2C ).
Similar to the 3D EM reconstruction of human Cav3.1 (22) , the intracellular segments, including CaM, are largely invisible, despite addition of CaM. Instead, the map of Nav1.5 contains an extra appendage contiguous with VSDI, reminiscent of the amino-terminal domain (NTD) in NavPaS (15, 20) ( Figure S2C ). However, the resolution for the putative NTD is approximately 4.5-6 Å, insufficient for model building ( Figure 1C ). The final structural model of Nav1.5 contains 1151 residues, including the complete transmembrane domain, the extracellular segments, and the III-IV linker. Nine glycosylation sites were observed and one sugar moiety was assigned to each site ( Figure 1D ). On the resolved region, 278 disease-related mutations can be mapped, providing the framework for structural-guided mechanistic investigation of these disease variants (Tables S1-S3).
Pore blockade by quinidine
While TTX was well-resolved in Nav1.5-TC, that of STX was only resolved as a blob congesting the entrance to the SF in Nav1.5-QS ( Figure S4B ,C). STX was not modelled. The two structures will hereafter be referred to as Nav1.5T and Nav1.5Q for complexes with TTX and quinidine, respectively. Unlike Cav1.1 and Cav3.1, which undergo main chain shift of the pore-forming S6 segments when binding to pore blockers such as diltiazem, verapamil, and Z944 (22, 23) , the two structures of Nav1.5 remain nearly identical the root-mean-square deviation (RMSD) of 0.16 Å over 771 Cα atoms ( Figure 2A ).
Similar to the structures of EeNav1.4, human Nav1.2 and Nav1.4, a density that likely belongs to the detergent glycol-diosgenin (GDN) penetrates the intracellular gate of Nav1.5T ( Figure S4B ). However, the GDN density is gone in Nav1.5Q because it would clash with the bound quinidine, which is localized in the central cavity of the pore domain ( Figure 2B ).
The distinctive shape of the quinolone double ring and the quinuclidine "cage" in quinine facilitates ligand fitting into the density ( Figure 2C ). Consistent with its function as a pore blocker, quinidine is positioned right beneath the SF, with the quinolone plane approximately perpendicular to the central axis and the quinuclidine group further down to the central cavity. Quinidine is coordinated by both polar and hydrophobic residues from repeats I, III, and IV, but distanced from repeat II. Therefore it is off the central axis ( Figure 2B ,D).
Three polar residues, Gln371, Thr1417, and Ser1759 are likely hydrogenbonded to the polar groups of quinidine. Gln371 and Thr1417, which are positioned at the bottom of SF in repeats I and III, respectively, appear to hang the blocker below the SF ( Figure 2D ). Quinidine is surrounded by multiple hydrophobic residues from the S6 segments in the three repeats, among which Phe1760 from S6III appears to play a major role through -π packing ( Figure 2D ). Supporting this notion, single point mutation F1760A led to increased IC50 from 40.3 ± 1.1 μM to 239.3 ± 1.2 μM, whereas Ala substitution of Phe402, which interacts quinidine through van der Waals contact, only results in marginal increase of IC50 to 84.8 ± 1.3 μM ( Figure   2E ).
Despite the lack of main chain shifts, Tyr1767, the intracellular gating residue on S6IV undergoes local changes. In Nav1.5T, Tyr1767 is well-resolved with its aromatic ring pointing up, leaving space for GDN. In Nav1.5Q, the density for Tyr1767 becomes much poorer, suggesting its flexibility. Nevertheless, it can no longer keep the original conformation, which would be incompatible with the bound quinidine. The most likely assignment for Tyr1767, indicated from low-thresh hold map, is to flip down to close the intracellular gate, similar to the corresponding residue Tyr1755 in Nav1.7 (19) (Figure 2F ,G, Figure S4D ). Therefore, in addition to directly blocking ion conduction at an upper site, quinidine may also facilitate gate closure.
Molecular determinant for TTX-resistance
The guanidinium pore blocker TTX has been used as a probe for characterizing Nav channels (24) (25) (26) (27) . The nine mammalian Nav channels have been classified to TTXsensitive and TTX-resistant (TTXr), the latter containing Nav1.5/1.8/1.9 because they can only be blocked by TTX at micromolar range (27, 28) . Sequence comparison and mutagenesis characterizations have pinpointed the determinant to be the replacement of a Tyr or Phe on the pore helix P2I in TTXr by Cys in Nav1.5 or Ser in Nav1.8/1.9 (27, (29) (30) (31) . Structures of TTX-bound NavPaS at 2.6 Å and Nav1.7 at 3.2 Å show that Tyr is placed close to the guanidinium group (19, 20) . We had speculated the hydroxyl group of Tyr to form water-mediated hydrogen bond with TTX, which was challenged by the presence of Phe at this locus in some TTXs Nav channels. We then attributed the interaction between the aromatic ring of Tyr and the positively charged guanidinium group to an unideal π-cation interaction, because their distance is about right, but the electronegative point of the Tyr and the guanidinium group is not optimally aligned for πcation interaction. Now with the structure of Nav1.5T, additional mechanistic insight can be obtained for understanding TTXr and TTXs Nav channels.
The binding site for TTX in Nav1.5, mainly constituted by acidic residues at the outer mouth to the SF, is identical to that in NavPaS and Nav1.7 (19, 20) . We will focus on Nav1.7 for comparison ( Figure 3A,B ). As predicted, Cys373 on P2I in Nav1.5, which occupies the same locus for Tyr362 in Nav1.7, is not involved in TTX coordination. On repeat III, Nav1.7 has two outliers, Thr1409/Ile1410, whose corresponding residues are Met/Asp in other human Nav channels, including Nav1.5, and Leu/Gln in NavPaS (20) .
Consistent with our previous prediction, the backbone amide of Met1422 and the carboxylate of Asp1423 in Nav1.5 interact with the C10-OH and C11-OH of TTX, respectively (19) (Figure 3A,B ).
With the reference structure of TTX-bound Nav1.5, it becomes clear that one additional role of Tyr362 is to stabilize two invariant Glu residues, Glu364 on repeat I and Glu930 on repeat II in Nav1.7, both directly engaging in TTX binding. When the bulky Tyr is replaced by the short side chains of Cys or Ser, there is a large void to confer flexibility for the two Glu residues, which may result in reduced affinity for TTX ( Figure   3C ). In addition, Tyr362 may also contribute to TTX binding by van der Waals contact with the C4 carbon ( Figure 3C ). These analyses are compatible with Phe at this locus.
Structural variations between human Na v channels
Although we have been attempting to capture Nav channels in distinct conformations, it is unsurprising that all the structures of human Nav channels exhibit similar, potentially inactivated conformations. These, disappointing at first glance, actually afford a good opportunity to establish the structure-function relationship of different Nav channels.
When the sequences of the nine human Nav channels are mapped to the structure of Nav1.5 using Consurf (32) , it is evident that the extracellular segments represent the least conserved region ( Figure 4A ). Consistently, when the structures of human Nav1.2/1.4/1.5/1.7 are superimposed, the extracellular loops deviate the most ( Figure 4B ). Compared to the rigorously characterized transmembrane region of the pore domain and VSDs, which are responsible for the fundamental functions of any voltage-gated ion channel, the extracellular segments have been underexplored. Comparison of the four human Nav structures in complex with distinct modulators reveals functional significance of the extracellular loops.
Extracellular segments confer specific Na v modulation
The deviation of the extracellular segments is not only in the conformation. Even the secondary structures vary because of the marked difference in length and amino acid composition ( Figure 5A ). In addition, these segments are enriched of residues for glycosylation and disulfide-bond formation, which add another tier of complexity in the modulation of Nav and the closely related Cav channels.
As described earlier, despite co-expression with the β1 subunit, no density is found for β1 ( Figure 1C , Figure S2C ). Structural comparison of Nav1.5 with the Nav1.4-β1 complex reveals the molecular basis for the lack of β1 association ( Figure   5B ). The primary element is the conformation of the loop following the extracellular helix Eα1, which we will refer to as the Lid loop for its position right above the SF ( Figure 5A,B) . The Lid is positioned lower toward the SF in Nav1.5 than in Nav1.4, resulting in a potential steric hindrance with the hairpin loop between the β2 and β3 strands in the β1 subunit ( Figure 5B , inset). More importantly, the residue at the tip of the lid loop is Asn318, a glycosylation site unique to Nav1.5 among the nine subtypes ( Figure 5A,B) . The sugar moieties would clash with β1. Upward movement of the loop, which may potentially change the position of Asn318 and the attached glycan to avoid the steric clash, is restricted by the interaction between Arg376 on P2I and Asp322 on the Lid. Note that the locus for Arg376 is occupied by Arg or Lys in TTXr and Asn in TTXs channels ( Figure 5A ). There is no interaction between the corresponding Asn and Lid residues in Nav1.2/1.4/1.7, hence Lid can be liberated to adopt a higher position ( Figure 5C ).
The extracellular region harbors the primary binding sites for various peptidic toxins in addition to the β subunits (18, 20) . Conformational change of the extracellular loops thereby also underscores the varied toxin sensitivity by different Nav subtypes. For instance, it has been shown that Nav1.2 can be blocked by μconotoxin KIIIA almost irreversibly, whereas the IC50 for the rat Nav1.5 is ~ 284 μM (33) . Structure-based sequence analysis has revealed three KIIIA binding residues in Nav1.2 that are altered in Nav1.5, Asp330Asn318, Tyr362His350, and Tyr1443Trp1440 (18) . Structural comparison between Nav1.5 and KIIIA-bound Nav1.2 affords additional insight for the distinct sensitivity toward KIIIA.
The Tyr1443Trp1440 variation may have little or no effect on KIIIA binding, because the -cation interaction is preserved. Tyr362His350 can lead to reduced affinity because of the loss of one hydrogen bond with Trp8 on KIIIA ( Figure 5C ). Glycosylated Asn318 by the residue per se can still form a hydrogen bond with KIIIA-Asn3; however, it is the conformation of the lid loop that leaves it out of reach of interacting with any residue on KIIIA ( Figure 5C ). Last but not least, the L5II loop, a short loop between S5 and P1 helix in repeat II, exhibits different conformations because Nav1.5 lacks a disulfide bond that is only conserved in TTXs subtypes ( Figure 5A,C) . The conformational shift of L5II may also contribute to the affinity difference with KIIIA.
When the four human Nav structures are superimposed, VSDII of Nav1.5 deviates from the other three by slight rotation, although it also exhibits a similar "up" conformation as VSDIIs in the other three channels (Figures 4B,5B) . The sequences of the transmembrane segments are highly conserved between Nav1.5 and the other three Nav channels (17) . The structural shifts are thus likely owing to the interaction between VSDII and other segments. As the transmembrane helices are nearly unchanged, we examined the interface at the extracellular region. Nav1.5 has a unique Tyr1434 on L6III, a locus that is occupied by Val in Nav1.2/1.5 and Lys in Nav1.4 ( Figure 5A ). Because of this bulky residue, a conserved Tyr on the S1-S2 loop in VSDII has to shift slightly. Although it is only a relatively minor change, this Tyr residue (Tyr739 in Nav1.5) appears to be the pivoting center for the overall shift of VSDII. Therefore, the positional change of Nav1.5-VSDII is in part because of an allosteric result from the alternation of the extracellular segments ( Figure 5D ).
We cannot exclude the contribution of other factors that are invisible in the present 3D reconstruction. For instance, site 4, i.e., the extracellular segments of S3 and S4 and the intervening linker of VSDII, is completely different between Nav1.5 and the other three Nav channels (Figure 5A, inset) . Accordingly, the structure of the S3-S4 loop in Nav1.5 deviates from that in Nav1.2. Its interaction with the indiscernible detergents or lipids may also contribute to the positional shift of VSDII.
In addition, the invisible intracellular segments may also play a role for the conformational deviation of VSDII.
Discussion
In this paper, we report the structures of human Nav1.5 bound to TTX or quinidine.
As this is the fourth human Nav channel whose structure has been elucidated, we hereby try to avoid describing the common structural features and mechanisms that have been previously described in detail, including the overall architecture, Na + path through SF, VSDs, fast inactivation mechanism, intracellular gating and fenestrations. Instead, we focus on comparative structural analysis in the hope to provide an advanced understanding of the uniqueness of different Nav channels.
During this manuscript preparation, cryo-EM structures of a rat Nav1.5 variant that contains truncations in the I-II linker, the II-III linker, and the Cterminus was reported in complex with TTX and flecainide, a class Ic antiarrhythmic drug (34) . There are only two overlapping points between the published paper and our present study, the molecular basis for TTX-resistance and the lack of β1 association. Of particular note, we have different interpretations for the same structural observations. Jiang and co-workers attributed the role of Tyr for TTX binding in TTXs channels as - packing, which has not been observed in our reported structures of TTX-bound NavPaS or Nav1.7. In Figure 3B , we provide a detailed analysis. With respect to β1 association, both studies identified the glycosylated Asn318 to impede β1 binding. However, our analysis indicates that the conformation of the Lid loop, which is locked by Arg376 in Nav1.5, determines the specific position of Asn318. If the Lid loop in Nav1.5 can exhibit the same conformation as that in Nav1.2/1.4/1.7, Asn318 would be oriented to an opposite direction that has no collision with β1, as seen for Glu352 in Nav1.4 ( Figure 5B, inset) .
In addition to the differences in interpreting the same structural observation, we hereby mainly focus on the structural distinctions between Nav1.5 and the previously reported Nav structures. Comparative analysis has identified the extracellular loops above the pore domain to be important determinants for subtypespecific channel modulation by different auxiliary subunits and toxins, and potentially other channel properties. Supporting the functional significance of the extracellular loops, nearly 40 mutations associated with LQT3 or Brugada syndrome are mapped to the extracellular loops (Tables S1, S2). Most of these residues are well-resolved. Although some of the mutations, such as C1363Y and C1728R/W, may compromise structural stability because of the disruption of disulfide bonds, the functional relevance of the majority of these disease residues is not immediately clear, as they do not participate in intra-protein interactions. It remains to be investigated whether the pathogenic mechanism of these residues involves binding factors or channel folding and membrane trafficking.
In sum, elucidation the cryo-EM structures of human Nav channels from different tissues affords unprecedented opportunity for establishment of the structure-function relationship. The boxed comparison is for site 4, the segment between S3 and S4 in VSDII. The alignment was adapted from our previous publication with modifications (17) . Invariant amino acids are shaded yellow and conserved residues are colored blue. The unique residues that are discussed in panels B-D are shaded with dark colors. G: Nav1.5-unique glycosylation site (Asn318). Y: Only Nav1.5 has a bulky residue (Tyr1434) at this locus. C: The disulfide bond that is conserved in TTX-sensitive Nav channels only. The Uniprot IDs for the aligned sequences are: Nav1.1: P35498; Nav1.2: Q99250; Nav1.3: Q9NY46; Nav1.4: P35499; Nav1.5: Q14524; Nav1.6: Q9UQD0; Nav1.7: Q15858; Nav1.8: Q9Y5Y9; Nav1.9: Q9UI33. (B) Structural basis for lack of β1 association with Nav1.5. Several factors, particularly the distinct conformation of the "Lid" loop, may prevent Nav1.5 from binding to the immunoglobulin (Ig) domain of the β1 subunit. Structures of Nav1.5 and β1-bound Nav1.4 are superimposed. An enlarged view of the interface between β1-Ig (gold) and the extracellular loops of Nav1.4 (pink) and Nav1.5 (domain colored) are shown. The corresponding residues in Nav1.4 and Nav1.5 are shown as thin and thick sticks, and the Nav1.4 residues are labeled in brackets. "Lid" refers to the loop that is 
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